Gigantic retroperitoneal leiomyosarcoma - case report
Journal Title: Współczesna Onkologia - Year 2007, Vol 11, Issue 2
Abstract
Retroperitoneal leiomyosarcomas are very rare malignant neoplasms. They are built up of smooth muscle cells. They can be found beyond the retroperitoneal space in the uterus, the stomach, the intestines, the blood vessel walls and the skin. This type of tumour grows slowly and gives no characteristic clinical symptoms. This results in late diagnosis, when they grow to a huge size. Retroperitoneal leiomyosarcomas are most frequently described in the literature in the fifth or sixth decade of life. There are no biochemical markers which could suggest the development of leiomyosarcoma. The basic diagnostic examination includes: ultrasound and computer tomography of the abdomen. The fundamental treatment of retroperitoneal leiomyosarcomas consists in aggressive surgical treatment – complete tumour resection. Large size of the tumour can make it difficult to perform radical surgery. In the case presented in this report, our team managed to remove a retroperitoneal leiomyosarcoma completely despite its huge mass and size (300x200 mm). Data from the literature indicate that a complete resection of the tumour is the most significant prognostic factor in the case of patients with retroperitoneal leiomyosarcoma. The efficacy of radiotherapy and chemotherapy has not been proved. The other unfavourable prognostic factor in the course of sarcomas is the age of the patient, below 50 years old. The patient presented in the report is a 31-year-old woman, which is associated with a worse prognosis. According to some authors, the size of the tumour is not significant for the fast recurrence of the disease, whereas others state that it is. The case was presented because of such a huge leiomyosarcoma being rarely found in the retroperitoneal space, the age of the patient and the asymptomatic course of the disease.
Authors and Affiliations
Jadwiga Snarska, Hady Razak Hady, Fabian Kamiński, Sławomir Dariusz Szajda, Dorota Werel, Lech Zimnoch, Andrzej Siemiątkowski
Keywords
Related Articles
- EP ID EP144419
- DOI -
- Views 70
- Downloads 0
Nowe możliwości leczenia kwasem zoledronowym przerzutów do kości w przebiegu raka gruczołu krokowego, na tle zdobyczy badań molekularnych
Rak gruczołu krokowego jest nadal poważnym wyzwaniem. Na świecie stale obserwuje się ogromną liczbę zachorowań. Rak gruczołu krokowego jest głównie rozpoznawany w krajach wysoko uprzemysłowionych. Sposób odżywiania i try...
Controversies related to the use of agents with a potential anticancer activity
Discoveries of antitumoral potential of commonly used, non-oncological drugs have appeared regularly in the medical journals all over the years. Information on such agents as statins, COX-2 inhibitors or inhibitors of AC...
Rola IMRT w redukcji dawki promieniowania w odbytnicy w trakcie radykalnej radioterapii raka gruczołu krokowego
Cel pracy: Celem pracy było porównanie dwóch technik napromieniania raka gruczołu krokowego – IMRT vs 3D- -CRT – pod względem dawek zdeponowanych w odbytnicy. Materiał i metody: W badaniu wykorzystano dane (przekroje t...
Lesniowski-Crohn disease and colon cancer
Non-specific, granulomatous inflammation of the colon called Lesniowski-Crohn disease is one of the chronic illnesses predisposing to the large intestine cancer. The prevalence of this disease increases in proportion wit...
Central Giant Cell Granuloma of the mandible in a different clinical aspect:a review of literature and own observations
The central giant cell granuloma is a tumor-like lesion according to WHO classification. It is an uncommon lesion located in the maxillo-mandibular region (7%) with the great number of osteoclastic origin giant cells....